Arcturus Therapeutics Holdings Inc
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 cli… Read more
Market Cap & Net Worth: Arcturus Therapeutics Holdings Inc (ARCT)
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) has a market capitalization of $186.17 Million ($186.17 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #15828 globally and #6145 in its home market, demonstrating a -14.04% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Arcturus Therapeutics Holdings Inc's stock price $6.55 by its total outstanding shares 28423069 (28.42 Million).
Arcturus Therapeutics Holdings Inc Market Cap History: 2015 to 2026
Arcturus Therapeutics Holdings Inc's market capitalization history from 2015 to 2026. Data shows change from $1.25 Billion to $186.17 Million (-17.06% CAGR).
Index Memberships
Arcturus Therapeutics Holdings Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.20 Trillion | 0.01% | #420 of 976 |
|
NASDAQ Composite
IXIC
|
$32.97 Trillion | 0.00% | #1486 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.51 Trillion | 0.01% | #218 of 263 |
Weight: Arcturus Therapeutics Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Arcturus Therapeutics Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Arcturus Therapeutics Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.59x
Arcturus Therapeutics Holdings Inc's market cap is 2.59 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
17.26x
Arcturus Therapeutics Holdings Inc's market cap is 17.26 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $417.82 Million | $20.38 Million | -$24.60 Million | 20.50x | N/A |
| 2017 | $225.96 Million | $13.00 Million | -$10.90 Million | 17.38x | N/A |
| 2018 | $128.76 Million | $15.75 Million | -$21.79 Million | 8.17x | N/A |
| 2019 | $308.96 Million | $20.79 Million | -$25.99 Million | 14.86x | N/A |
| 2020 | $1.23 Billion | $9.54 Million | -$72.15 Million | 129.26x | N/A |
| 2021 | $1.05 Billion | $12.36 Million | -$203.67 Million | 85.12x | N/A |
| 2022 | $482.06 Million | $205.75 Million | $9.35 Million | 2.34x | 51.56x |
| 2023 | $896.18 Million | $157.75 Million | -$29.73 Million | 5.68x | N/A |
| 2024 | $482.34 Million | $138.39 Million | -$80.94 Million | 3.49x | N/A |
| 2025 | $174.23 Million | $67.22 Million | $10.10 Million | 2.59x | 17.26x |
Competitor Companies of ARCT by Market Capitalization
Companies near Arcturus Therapeutics Holdings Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Arcturus Therapeutics Holdings Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Arcturus Therapeutics Holdings Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Arcturus Therapeutics Holdings Inc's market cap moved from $1.25 Billion to $ 186.17 Million, with a yearly change of -17.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $186.17 Million | +6.85% |
| 2025 | $174.23 Million | -63.88% |
| 2024 | $482.34 Million | -46.18% |
| 2023 | $896.18 Million | +85.91% |
| 2022 | $482.06 Million | -54.17% |
| 2021 | $1.05 Billion | -14.68% |
| 2020 | $1.23 Billion | +299.08% |
| 2019 | $308.96 Million | +139.96% |
| 2018 | $128.76 Million | -43.02% |
| 2017 | $225.96 Million | -45.92% |
| 2016 | $417.82 Million | -66.56% |
| 2015 | $1.25 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Arcturus Therapeutics Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $186.17 Million USD |
| MoneyControl | $186.17 Million USD |
| MarketWatch | $186.17 Million USD |
| marketcap.company | $186.17 Million USD |
| Reuters | $186.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.